Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityActive in the last 2 years

Hongwei Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0323-4091; OpenAlex author ID A5101425418. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Metal-related cell death and its application in pancreatic cancer. Co-author DOI 10.1017/erm.2025.10022↗
  2. Corrigendum: Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26. Co-author DOI 10.3389/fimmu.2020.00277↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shengjie Dai · 2 shared papers, 2020–2025 · strength 0.35
  2. Tiantong Liu · 1 shared paper, 2025 · strength 0.24
  3. Chengchao Wang · 1 shared paper, 2025 · strength 0.24
  4. Mengtao Zhou · 1 shared paper, 2020 · strength 0.11
  5. Keqing Shi · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.